UNSPSC 51383312: Diclofenac epolamine

This classification denotes a cyclooxygenase inhibitor C14H11Cl2NO2.C6H13NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier X5F8EKL9ZG, chemically known as benzeneacetic acid, 2-((2,6-dichlorophenyl)amino)-, compd. with 1-pyrrolidineethanol (1:1), but more generally known as diclofenac epolamine, which bears US NIH Compound Identifier 114753. European Medicines Agency schedules Diclofenac epolamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB20558.

Most nations, for tariff and trade purposes, schedule diclofenac epolamine under HS 29224995 and SITC 51465. As of Q4 2014, DICLOFENAC EPOLAMINE remains US FDA's Preferred Term for this commodity. Diclofenac epolamine bears US NLM identifiers UMLS ID C0082274 and NCI Concept Code C77355. SMILES: C1CCC(C(C1)CC(=O)O)NC2C(CCCC2CL)CL.C1CCN(C1)CCO.

UNSPSC 51383312 Diclofenac epolamine is a Commodity code for a specific nonsteroidal anti-inflammatory drug product. State and local procurement activity under this code shows minimal recent volume. The single recent opportunity in the database — Seminole County, Florida's IFB 60459723LAS, posted June 30, 2026 with a July 26, 2023 response deadline — solicits naloxone and drug deactivation systems for community health initiatives, not diclofenac epolamine. This mismatch suggests the code is either incorrectly tagged in the opportunity or carries little active procurement use in the state and local market at present.

The Seminole County opportunity represents demand from a county health department for quarterly deliveries of naloxone and deactivation systems to support opioid emergency response, with a two-year initial term and optional one-year renewal on a fixed-fee basis. Geographic activity centers on Florida, based on available records. The scope of work reported under this code does not align with the pharmaceutical product the code nominally names, indicating either a data tagging error or dormant procurement activity for diclofenac epolamine itself in the state and local sector. Business development professionals should verify whether this code accurately describes their product or service offering before investing pursuit effort.